Quarterly ResultJul 30, 2026, 04:14 PM
Illumina Q2 Revenue $1.16B, EPS $1.35; Raises FY26 Guidance
AI Summary
Illumina announced strong financial results for the second quarter of fiscal year 2026, with revenue reaching $1.16 billion, a 9.5% increase year-over-year. GAAP diluted EPS was $1.35 and non-GAAP diluted EPS was $1.31. Following this performance, the company raised its full-year 2026 revenue guidance to $4.60-$4.64 billion and non-GAAP diluted EPS guidance to $5.30-$5.40. CEO Jacob Thaysen highlighted continued momentum and high demand for NovaSeq X.
Key Highlights
- Q2 2026 Revenue: $1.16 billion, up 9.5% from Q2 2025.
- Q2 2026 GAAP Diluted EPS: $1.35.
- Q2 2026 Non-GAAP Diluted EPS: $1.31.
- FY2026 Total Revenue Guidance raised to $4.60-$4.64 billion (from $4.52-$4.62 billion).
- FY2026 ROW Organic Revenue Growth Guidance raised to greater than 5% (from 2%-4%).
- FY2026 Non-GAAP Diluted EPS Guidance raised to $5.30-$5.40 (from $5.15-$5.30).
- Q2 2026 GAAP Operating Margin: 21.1%.
- Q2 2026 Non-GAAP Operating Margin: 22.5%.
Price Impact
More from ILMN